Lepu Bio
Shanghai · Founded 2018
About Lepu Bio
Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $346.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2024)
- Ticker: hkg:2157
- Website: en.lepubiopharma.com
- Phone: +86 021-67680899
Industries & Categories
Biotechnology, Health Care, Medical, Service Industry, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lepu-bio-109512 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.